Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis
Giovanna Fattovich1, Giuliano Giustina2, José. Sanchez-Tapias3, Carlos Quero4, Anna Mas3, Pia Grazia Olivotto4, Antonio Solinas5, Piero Almasio6, Stephanos Hadziyannis7, Francoise Degos8, Miguel Carneiro de Moura9, Kim Krogsgaard10, Maurizio Pantalena1, Giuseppe Realdi11, Roberto Corrocher1, Solko W. Schalm4
1Istituto di Patologia Speciale Medica, Cattedra di Medicina Interna, University of Verona, Verona, Italy
2Dipartimento di Medicina Clinica e Sperimentale, Clinica Medica 2a, University of Padova, Padova, Italy
3Liver Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain
4Internal Medicine II, Erasmus University Hospital Dijkzigt, Rotterdam, The Netherlands
5Istituto di Patologia Speciale Medica, University of Sassari, Sassari, Italy
6Istituto di Clinica Medica I, University of Palermo, Palermo, Italy
7Academic Department of Medicine, Hippokration General Hospital, Athens, Greece
8Fédération d’Hépatogastroentérologie et INSERM U24, Hôpital Beaujon, Paris, France
9Servico de Medicina II, Medical School of Lisbon, Lisbon, Portugal
10Institute of Preventive Medicine, Kommunehospitalet, Copenhagen, Denmark
11Istituto di Clinica Medica, University of Sassari, Sassari, Italy
Thông tin
Thông tin xuất bản
The American Journal of Gastroenterology
Tập 93
896-900
Thông tin tác giả